Considering that the development of liver fibrosis is strongly associated with overweight/obesity, insulin resistance and steatosis [7,47,48], we think that the association between the FTO rs9939609 polymorphism and liver fibrosis might be mediated by the metabolic disorders related to CHC. Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.